MICHAEL EHLERS

Profile

First Name

: MICHAEL

Middle Name

:

Last Name

: EHLERS

Related Companies

Titles

Company Name

Related People

DIRECTOR

OPAL BIOSCIENCES, INC.

RAJESH CHOPRA, JAMES H. DOUDNA CATE, SETH HARRISON, SPIROS LIRAS

DIRECTOR

NINE SQUARE THERAPEUTICS, INC.

SETH HARRISON, MATTHEW JACOBSON, SPIROS LIRAS

DIRECTOR, EXECUTIVE OFFICER

AULOS BIOSCIENCE, INC.

YECHEZKEL BARENHOLZ, ANNA BATARINA, RAJESH CHOPRA, SETH HARRISON, ARON KNICKERBOCKER, YANAY OFRAN, MICAH PEARLMAN, LEO J. REDMOND, MACE ROTHENBERG, JAMES VASSELLI, JOSEPH YANCHIK

DIRECTOR

INITIAL THERAPEUTICS, INC.

RAJESH CHOPRA, JAMES H. DOUDNA CATE, SETH HARRISON, SPIROS LIRAS

DIRECTOR

NINE SQUARE THERAPEUTICS CORP

SETH HARRISON, MATTHEW JACOBSON, SPIROS LIRAS

EXECUTIVE OFFICER, DIRECTOR

REPLICATE BIOSCIENCE, INC.

SETH HARRISON, NATHANIEL WANG, JOSEPH YANCHIK

DIRECTOR

DEEP APPLE THERAPEUTICS, INC.

PAUL DA SILVA JARDINE, SETH HARRISON, SPIROS LIRAS, BRIAN SHOICHET

DIRECTOR

REUNION NEUROSCIENCE, INC.

ROBERT ALEXANDER, NATHAN BRYSON, ANSBERT GADICKE, ALON LAZARUS, ELLEN LUBMAN, GREGORY MAYES, BRIGGS MORRISON, MARK POLLACK, NATALIE SACKS, EDWARD SMITH, MARK THEEUWES

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2024-01-12

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2024-01-12

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2023-07-28

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-02-04

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-12-06

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-02-04

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-07-02

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-06-16

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-10-30

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-07-02

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-06-16